Company Overview

PRIME exits and American HealthCare Capital are pleased to introduce an established and growing, locally owned urgent care practice in the Southeast. The company started business operations in 2016 at their first location and were profitable within months. While there was a hospital based Urgent Care in the local area, the owners felt there was an obvious need for a more robust urgent care that provided more extensive services with a personalized approach. A couple of years later, they opened a second location in a small, rural community in a medically underserved area with significant industry, located in close proximity to an affluent community. Most recently in 2022, a 3rd location was opened in a location near a University. This area has a very stable educational, governmental, and high-tech work force.

The owners have invested heavily in their employees’ welfare, and this has paid off with a high retention rate and outstanding Google reviews from patients. The providers are physician assistants (PAs) who bring years of experience and different specialties to the practice. They have extensive expertise in musculoskeletal medicine and provide advanced orthopedic services to patients not found in most urgent cares. They have certified radiological techs, which is not common to urgent cares.

This business has grown from a one clinic practice with a handful of employees, to a three-clinic practice that served nearly 40,000 patients in 2024 over a 10 county area. They provide emergency department level care and remained open during the COVID pandemic when many of the other local urgent cares and primary care clinics closed their doors. They have developed a large and loyal patient base who remember that they were available when others were not, and they feel they will be able to leverage their brand name into continued robust growth in the future.

Financial Overview

The company saw consistent growth since its inception through 2022. Similar to many other urgent care businesses, they had a spike in business due to the COVID pandemic that peaked in 2022 and has since begun to normalize. The company grossed over $5.4 million in 2024 and expects similar results in 2025.

Staff and Exit Plan

The owners are seeking a larger strategic buyer who will have better negotiating power for insurance contracts and employee benefits. All staff, including a comprehensive team of administrative and clinical personnel, are expected to stay on under new ownership.

Asking Price

The asking price for the opportunity is $6 million, which does not include cash, receivables, or working capital.